Framingham Risk Score for Hard Coronary Heart Disease
ورودیهای بالینی بیمار
حداقل ۳۰ — حداکثر ۷۹ • واحد: years
حداقل ۱۰۰ — حداکثر ۴۰۰ • واحد: mg/dL
حداقل ۲۰ — حداکثر ۱۰۰ • واحد: mg/dL
حداقل ۹۰ — حداکثر ۲۰۰ • واحد: mmHg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5
- Borderline Risk5–10
- Intermediate Risk10–20
- High Risk20–100
The Framingham Risk Score for Hard Coronary Heart Disease calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates 10-year risk of myocardial infarction in patients aged 30-79 with no history of coronary heart disease or diabetes
Clinical Indication
The Framingham Risk Score for Hard Coronary Heart Disease is indicated for bedside clinical practice to support Estimates 10-year risk of myocardial infarction in patients aged 30-79 with no history of coronary heart disease or diabetes. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Not recommended for patients with diabetes or known coronary heart disease.
Gender-specific logarithmic regression equation using age, cholesterol levels, blood pressure, smoking status, and treatment history
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| sex | string | Yes | Patient sex |
| total_cholesterol | float | Yes | Total cholesterol level(mg/dL) |
| hdl_cholesterol | float | Yes | HDL cholesterol level(mg/dL) |
| systolic_bp | integer | Yes | Systolic blood pressure(mmHg) |
| bp_treatment | string | Yes | Currently taking blood pressure medication |
| smoking | string | Yes | Current smoker |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Low Risk | Low 10-year CHD risk |
| 5–10 | Borderline Risk | Borderline 10-year CHD risk |
| 10–20 | Intermediate Risk | Intermediate 10-year CHD risk |
| 20–100 | High Risk | High 10-year CHD risk |
Evidence-Based References (EBM)
- Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.DOI: 10.1161/01.cir.97.18.1837
- D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579.DOI: 10.1161/CIRCULATIONAHA.107.699579
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. doi: 10.1001/jama.285.19.2486.DOI: 10.1001/jama.285.19.2486